Safety Presentation on
 NDA 21-814
Tipranavir
Andrea N. James, M.D.
Primary Medical Reviewer
Division of Antiviral Drug Products
Food and Drug Administration
May 19, 2005 FDA Antiviral Drugs Advisory Committee Meeting